Skip to main content
. Author manuscript; available in PMC: 2022 Feb 25.
Published in final edited form as: Gastrointest Endosc. 2021 Apr 19;94(4):760–773.e18. doi: 10.1016/j.gie.2021.04.009

Figure 2.

Figure 2.

Consensus-based flowchart. Percentages indicate degree of agreement. CBD, Common bile duct; CT, computed tomography; EUS, endoscopic ultrasound; FU, follow-up; HGD, high-grade dysplasia; LGD, low-grade dysplasia; LSL, laterally spreading lesion; MRCP, magnetic resonance cholangiopancreatography; MRI, magnetic resonance imaging, NSAID, nonsteroidal anti-inflammatory drug; PD, pancreatic duct.